Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

25/05/2017
Both adjusted revenue and ebitda continued on an upward trajectory at Four Seasons Health Care Group in the first quarter of 2017.
23/05/2017
BC Partners, the international private equity firm, has acquired Italian dentistry group DentalPro from Summit Partners, VAM Investments, and other private investors.
23/05/2017
Sanctuary Group has acquired three turnkey properties from LNT Care Developments, the developer of purpose-built residential care homes.
23/05/2017
Theresa May has backtracked on her party’s bold new plan for social care, just days after the manifesto was published.
22/05/2017
August Equity is looking to sell Compass Community, a children’s fostering and residential care group, HealthInvestor UK can reveal.


HealthInvestor Events


children's services special report
- part 2

Success at Witherslack Group has been driven by a focus on high acuity cases and a substantial support structure for teachers, finds Ploy Radford
Read more



deal in the spotlight
A new REIT embarked onto the London Stock Exchange in March. Investment advisor Andrew Cowley charts Impact's development and plans for the future
Read more
Christie + Co


children's services special report - 1

NFA Group boss Iain Anderson tells Ploy Radford about the rationale behind the acquisition of Acorn and how the merged entity will help transform children's services
Read more





opinion

Could public-private partnerships revive the provincial private patient market, asks Hugh Risebrow, chief executive of Latchmore Associates
Read more



HealthInvestor blog
The Conservative manifesto and the party’s likely win means we run the risk of a step back for social care

Click here to view the Editor's blog


Believe the polls, and June’s election will spell more of the same, with a renewed Tory majority bringing few changes for health and care. The polls, though, have much to prove. Sarah Williams weighs up what the different parties’ pledges could mean…
Partner at Albion Ventures, ex-neurosurgeon and former extreme-sports fan
Technology is a useful tool in mental as well as physical health and providers can pursue a global strategy, argues Candesic’s Dr Michelle Tempest
With the CMA due to publish its first interim report into competition in the elderly care home market, Sarah Williams looks into stakeholders’ responses to the regulator’s statement of scope
Turkish politics is at the centre of the geopolitical stage, but the recent ratings of senior bonds to fund a hospital project proves the country’s position in a noisy neighbourhood has not dented investor confidence. Nick Herbert reports

Click here to search all feature articles